• BI 2536: PLK1 Inhibitor Workflows for Cell Cycle and Cancer

  2026-06-22

  BI 2536 is a high-specificity PLK1 inhibitor that empowers researchers to dissect mitotic checkpoint regulation, induce G2/M cell cycle arrest, and model apoptosis in cancer cells with nanomolar precision. This article delivers actionable workflow guidance, protocol refinements, and troubleshooting insights informed by recent mechanistic breakthroughs and primary literature.

• Adipose-Neural Axis and NPY/Y1R in Arrhythmia Pathogenesis

  2026-06-22

  Fan et al. (2024) reveal that the adipose-neural axis, particularly through leptin-mediated activation of sympathetic neurons and subsequent NPY/Y1 receptor signaling, is a crucial driver of epicardial adipose tissue (EAT)-related cardiac arrhythmias. Their stem cell-based coculture approach highlights new therapeutic targets and offers a translationally relevant model for dissecting neuropeptide-driven cardiovascular pathology.

• Gamma-linolenic Acid (GLA): Antibacterial Resistance and Inf

  2026-06-21

  Explore Gamma-linolenic acid (GLA) as both a modulator of inflammatory pathways and a tool for dissecting antibacterial resistance. Uncover unique, actionable insights for anti-inflammatory research and advanced assay design.

• Protoporphyrin IX: Bridging Heme Synthesis and Ferroptosis T

  2026-06-20

  This thought-leadership article explores Protoporphyrin IX’s pivotal role as both a mechanistic regulator and a translational tool in the evolving landscape of heme biosynthesis, iron metabolism, and ferroptosis resistance in cancer. Integrating the latest mechanistic findings and workflow guidance, it provides actionable insights for researchers navigating the intersection of photodynamic compounds and liver oncology.

• A40926 (SKU BA1486): Reproducible Antibacterial Assays in Fo

  2026-06-19

  This article delivers scenario-driven, evidence-based guidance for integrating A40926 (SKU BA1486) into cell viability and antibacterial assays targeting Gram-positive and Neisseria gonorrhoeae pathogens. Drawing on MIC data, biosynthetic insights, and comparative workflow experience, it demonstrates how A40926 supports reproducible, high-sensitivity research outcomes for antibiotic development and resistant pathogen studies.

• Vorinostat (SAHA): Advanced Epigenetic Modulation in Oncolog

  2026-06-19

  Vorinostat (suberoylanilide hydroxamic acid) stands as a gold-standard HDAC inhibitor for precise epigenetic modulation and robust apoptosis induction in cancer biology research. This article presents actionable workflows, troubleshooting strategies, and highlights novel assay designs inspired by Pol II–independent cell death mechanisms.

• Entecavir (BMS200475): Optimizing HBV Replication Inhibition

  2026-06-18

  Entecavir, a potent HBV DNA polymerase inhibitor, sets the benchmark for reliable chronic hepatitis B virus replication inhibition and resistance modeling. This guide walks through advanced workflows, comparative insights, and troubleshooting strategies, translating recent meta-analytic findings into actionable laboratory protocols.

• ASB3 E3 Ligase Inhibits Antiviral Immunity by Targeting MAVS

  2026-06-18

  This study identifies ASB3 as a novel E3 ubiquitin ligase that negatively regulates antiviral innate immunity by promoting K48-linked polyubiquitination and degradation of MAVS. These findings clarify a previously unrecognized mechanism by which host cells can suppress type I interferon responses during RNA virus infection, with significant implications for understanding immune evasion.

• Indole-3-pyruvic Acid Modulates Immune Balance in RA via AhR

  2026-06-17

  This study demonstrates that indole-3-pyruvic acid (IPA) alleviates rheumatoid arthritis (RA) by restoring the Th17/Treg cell balance through activation of the aryl hydrocarbon receptor (AhR) pathway. The findings reveal a mechanistic basis for IPA's immunomodulatory effects and contribute new evidence to the therapeutic exploration of tryptophan metabolites in autoimmune disease.

• Mubritinib (TAK 165): Redox Homeostasis Insights for Next-Ge

  2026-06-17

  Explore how Mubritinib (TAK 165) enables advanced cancer biology research by targeting mitochondrial redox balance, with a unique perspective on NAD+/NADH homeostasis and practical assay design. Discover new scientific depth and workflow guidance for translational oncology.

• Spermine Tetrahydrochloride: Innovations in Polyphosphazene

  2026-06-16

  Explore how Spermine tetrahydrochloride revolutionizes polyphosphazene nanoparticle crosslinking and protein delivery. This in-depth analysis reveals unique mechanistic insights, application protocols, and assay design strategies for advanced biomedical research.

• Pam3CSK4 and Neuro-Immune Reflexes: Charting Next-Gen Inflam

  2026-06-16

  Explore how Pam3CSK4, a synthetic TLR1/2 agonist from APExBIO, is reshaping translational inflammation research by bridging innate immunity and neuro-immune modulation. Drawing on recent breakthroughs in neural reflex control of inflammation, this article delivers mechanistic insight, protocol guidance, and strategic perspective for researchers aiming to model and modulate complex immune pathways far beyond conventional workflows.

• IAM LC vs LEKC for Drug Permeability: Insights for HIV Resea

  2026-06-15

  This study systematically compares immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) for predicting pulmonary drug permeability. The findings highlight LEKC’s superior modeling of drug-membrane interactions, while clarifying the distinct strengths and limitations of each approach for early-stage antiretroviral drug research.

• A40926: Advanced Insights into Glycopeptide Engineering and

  2026-06-15

  Explore how A40926, a potent dalbavancin precursor, enables breakthroughs in glycopeptide antibiotic engineering and resistance research. This article provides a deeper technical analysis of biosynthetic regulation, aglycone activity, and assay design, delivering unique guidance for advanced antimicrobial development.

• Rotenone: Applied Protocols for Mitochondrial Complex I Inhi

  2026-06-14

  Rotenone remains an indispensable mitochondrial Complex I inhibitor for dissecting oxidative phosphorylation, apoptosis, and autophagy mechanisms in both cellular and animal models. This article provides actionable workflows, troubleshooting guidance, and practical insights for robust experimental design, leveraging APExBIO’s Rotenone and the latest advances in mitochondrial proteostasis research.

455 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page